Clinical Trials Using Bendamustine-Vorinostat Fusion Molecule EDO-S101
Clinical trials are research studies that involve people. The clinical trials on this list are studying Bendamustine-Vorinostat Fusion Molecule EDO-S101. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Tinostamustine with or without Radiation Therapy in Treating Patients with Newly Diagnosed MGMT-Unmethylated Glioblastoma
This phase I trial studies the side effects and best dose of tinostamustine (EDO-S101) given with or without radiation therapy in treating patients with newly diagnosed MGMT-unmethylated glioblastoma. Tinostamustine may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth in patients with glioblastoma.
Location: M D Anderson Cancer Center, Houston, Texas